Showing posts with label Ophthalmic Equipment Market. Show all posts
Showing posts with label Ophthalmic Equipment Market. Show all posts

Wednesday, June 12, 2024

The Future of Eye Care: Ophthalmic Equipment Market to Reach $88.5 Billion by 2029

 The global Ophthalmic Equipment Market is experiencing significant growth, with an estimated value of USD 66.2 billion in 2023 projected to reach USD 88.5 billion by 2029. This impressive expansion is driven by a compound annual growth rate (CAGR) of 4.9% over the forecast period. This blog post explores the key factors fueling this market's growth, from rising eye disorders to technological advancements and regional trends.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155637364

Growth Drivers:

Increase in Eye Disorders

The prevalence of eye-related disorders is on the rise, largely due to aging populations and increased exposure to UV screens. Common conditions include diabetic retinopathy, glaucoma, cataracts, corneal opacities, trachoma, and refractive error diseases. The growing incidence of diabetic retinopathy, in particular, has heightened the demand for advanced imaging and laser treatments. Innovations such as femtosecond lasers and phacoemulsification systems are transforming cataract surgeries, offering hope in the global fight against vision loss.

Growth Opportunities:

Low Adoption in Emerging Regions

Despite the effectiveness of phacoemulsification devices in cataract surgeries, their adoption remains low in emerging regions. In India, for example, only 17% of cataract surgeries use this technique, and premium lenses are employed in just 8% of these procedures. The high costs and limited reimbursement for these advanced technologies are key barriers to their widespread use.

Market Segmentation:

The ophthalmic equipment market is segmented by product, end-user, and region. Among these segments, vision care holds the largest market share. This is driven by the widespread need for corrective solutions like glasses and contact lenses to address refractive errors such as myopia, hyperopia, and astigmatism. The affordability and accessibility of these products make them a popular choice across all income levels.

Vision Care: A Leading Segment

Vision care products are not only functional but have also become fashion statements. With options ranging from designer frames to personalized lenses, individuals can find solutions that cater to both their vision needs and personal style. Technological advancements like blue-light filtering glasses and telehealth consultations continue to enhance the appeal of this segment.

The Consumer Segment

An aging population and increasing awareness of eye health are driving a surge in demand for vision correction solutions. Consumers are now more proactive about their eye health, seeking tools like autorefractors and tonometers for home use. Technological advancements have democratized access to eye health information, empowering individuals to monitor their vision and engage in preventive care.

Surgical Segment: Cataract Surgery Devices

Cataract surgery devices account for the largest share within the surgical segment. As the global population ages, the demand for cataract surgeries rises, driving the market for devices like phaco emulsifiers. Technological advancements have made cataract surgery minimally invasive and highly effective, boosting patient safety and recovery times.

Regional Analysis:

North America Dominates the Market

North America is expected to continue dominating the ophthalmic equipment market by 2029. Significant healthcare investments in the region foster a thriving research and development ecosystem, leading to constant innovation in diagnostic and treatment devices. Public awareness campaigns and robust healthcare systems further bolster this dominance.

Recent Developments in the Ophthalmic Equipment Industry:

  • September 2023: Carl Zeiss launched ZEISS trifocal technology on a glistening-free hydrophobic c-loop platform with a fully preloaded injector.
  • October 2023: Carl Zeiss collaborated with Boehringer Ingelheim to develop predictive analytics for early detection of eye diseases.
  • October 2022: Bausch Health Companies Inc. launched enVista Aspire IOLs with PureFlex design technology.
  • March 2022: Alcon launched the Clareon family of intraocular lenses (IOLs) in the US, offering consistent visual outcomes and exceptional clarity.

Top Key Players:

The ophthalmic equipment market features several dominant multinational players, including Bausch Health Companies, Inc. (Canada), Alcon (Switzerland), Carl Zeiss Meditec AG (Germany), Johnson & Johnson (US), Hoya Corporation (Japan), and many others.

Stay informed and ahead in the rapidly evolving field of ophthalmic equipment. With continuous advancements and growing awareness of eye health, the future of seeing clearly has never been brighter.

Read More about Related News:

https://www.prnewswire.com/news-releases/ophthalmic-equipment-market-worth-88-5-billion--marketsandmarkets-302034610.html

https://www.globenewswire.com/news-release/2024/02/05/2823421/0/en/Ophthalmic-Equipment-Market-is-Expected-to-Reach-88-5-Billion-MarketsandMarkets.html

 

Tuesday, December 5, 2023

Ophthalmic Equipment Market: Technological advancements in ophthalmic devices

 Increasing government initiatives to control visual impairment, technological advancements in ophthalmic devices, and the increasing adoption of contact lenses and spectacles are some of the key factors driving the market for ophthalmic equipment.

The report Ophthalmic Equipment Market  is projected to reach USD 80.9 billion by 2027 from USD 63.4 billion in 2022, at a CAGR of 5.0%.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155637364

KEY MARKET DYNAMICS

A. DRIVERS
                   1 Increasing geriatric population                   
                   2 Rising prevalence of eye disorders
                              
                   3 Technological advancements in ophthalmic devices

                   4 Increased government initiatives to control visual impairment
                   5 Rising adoption of contact lenses and spectacles          

B. RESTRAINTS
                   1 High cost and risk associated with eye surgeries
                   2 Increased cost of ophthalmology devices)

                   3 Rising adoption of refurbished ophthalmic devices
          

C. OPPORTUNITIES
                   1 Potential growth opportunities in emerging markets
                   2 Low adoption of phacoemulsification devices and premium IOLs in emerging regions
          

D. CHALLENGES
                   1 Low accessibility to eye care in low-income countries
                   2 Lack of skilled professionals

Market Segmentation:

·         Based on products, the ophthalmic equipment market is segmented into vision care products, surgical devices, and diagnostic and monitoring devices. The large share of the vision care products segment is attributed to the growing number of patients with refractive errors, increasing number of wearers, increasing prevalence of myopia, growing geriatric population, and increasing preference for contact lenses over prescription eyeglasses.

·         Based on end users, the market is segmented into consumers, hospitals, specialty clinics and ambulatory surgery centres, and other end users. The large share of consumers can be attributed to increasing emphasis on aesthetics, increasing usage of digital gadgets, growing adoption of spectacles and contact lenses among consumers.

Regional Analysis: -

In 2021, North America accounted for the largest share the ophthalmic equipment market. Market growth in this region is characterized by the high healthcare expenditure, rising geriatric population (and subsequent growth in the prevalence of eye diseases), and the availability of advanced ophthalmic devices in the country.

REQUEST FOR 10% CUSTOMIZATION: - https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=155637364

Recent Developments

  • In 2022, Alcon acquired Ivantis Inc. to help ensure continuity of the business and relationships with existing customers and allowing Alcon to begin its future growth plans to bring Hydrus Microstent to more international markets.
  • In 2020, Hoya Corporation formed joint venture with GeMax, a distributor partner. GeMax is a specialty promotion service provider of IOLs with a strong market position and a professional reputation in China, The joint venture is named as HOYA GeMax Medical (China).
  • In 2020, Bausch Health Companies Inc. announced the spin-off of its leading eye health business into an independent publicly traded entity ("Bausch + Lomb - NewCo") from the remainder of Bausch Health ("BHC"). It will consist of Bausch Health's global vision care, surgical, consumer and ophthalmic Rx businesses.

Top Key Players: -

The prominent players in the ophthalmic equipment market are Bausch Health Companies, Inc. (Canada), Alcon (Switzerland), Carl Zeiss Meditec AG (Germany), Johnson and Johnson (US), Hoya Corporation (Japan), The Cooper Companies, Inc.(US), EssilorLuxottica (France), Canon (Japan), Glaukos Corporation (US), Nidek Co., Ltd. (Japan), Topcon Corporation (Japan), Zeimer Ophthalmic Systems (Switzerland), Staar Surgical (US), Neo Vision (Korea), Clear Lab (Singapore), Appasamy Associates (India), Ophtec BV (Netherlands), Lumenis (Israel), and Intuvision Labs (India).

The Ophthalmic Equipment Industry is more than just a market; it's a beacon of hope for those seeking clarity in their vision. As someone deeply entrenched in the medical industry, I'm excited to witness this sector's growth as it advances towards a future where eye health knows no bounds. With continued advancements and global initiatives, the Ophthalmic Equipment Industry is set to make a profound impact on eye care worldwide.

 

Thursday, September 21, 2023

Clarity in Vision: Ophthalmic Equipment Industry's Global Growth Prospects

 Increasing government initiatives to control visual impairment, technological advancements in ophthalmic devices, and the increasing adoption of contact lenses and spectacles are some of the key factors driving the market for ophthalmic equipment.

The report Ophthalmic Equipment Market  is projected to reach USD 80.9 billion by 2027 from USD 63.4 billion in 2022, at a CAGR of 5.0%.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155637364

KEY MARKET DYNAMICS

          Driving Forces Several factors are steering the growth of the Ophthalmic Equipment Industry:

  1. Aging Population: The increasing geriatric population brings with it a higher prevalence of eye disorders, driving the demand for ophthalmic equipment.
  2. Rising Eye Conditions: The global rise in eye disorders necessitates advanced equipment for accurate diagnosis and treatment.
  3. Technological Evolution: Ophthalmic devices continue to evolve, offering more efficient and precise solutions for eye care.
  4. Government Initiatives: Governments worldwide are taking proactive measures to control visual impairment, contributing significantly to industry growth.
  5. Eyewear Adoption: The growing popularity of contact lenses and spectacles enhances the need for comprehensive eye examinations and vision correction.

Challenges and Opportunities In this dynamic landscape, challenges and opportunities coexist:

Challenges:

  1. High Costs: Eye surgeries come with significant costs and risks, limiting access for some patients.
  2. Device Expenses: The increasing cost of ophthalmology devices poses challenges for both providers and patients.
  3. Refurbished Devices: The growing adoption of refurbished ophthalmic equipment impacts the sales of new devices.

Opportunities:

  1. Emerging Markets: Untapped regions offer immense growth potential as awareness and access to eye care improve.
  2. Advanced Devices: There is a significant growth opportunity in the adoption of phacoemulsification devices and premium IOLs in emerging regions.

Market Segmentation:

·         Based on products, the ophthalmic equipment market is segmented into vision care products, surgical devices, and diagnostic and monitoring devices. The large share of the vision care products segment is attributed to the growing number of patients with refractive errors, increasing number of wearers, increasing prevalence of myopia, growing geriatric population, and increasing preference for contact lenses over prescription eyeglasses.

·         Based on end users, the market is segmented into consumers, hospitals, specialty clinics and ambulatory surgery centres, and other end users. The large share of consumers can be attributed to increasing emphasis on aesthetics, increasing usage of digital gadgets, growing adoption of spectacles and contact lenses among consumers.

Regional Analysis: -

In 2021, North America accounted for the largest share the ophthalmic equipment market. Market growth in this region is characterized by the high healthcare expenditure, rising geriatric population (and subsequent growth in the prevalence of eye diseases), and the availability of advanced ophthalmic devices in the country.

REQUEST FOR 10% CUSTOMIZATION: - https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=155637364

Recent Developments

  • In 2022, Alcon acquired Ivantis Inc. to help ensure continuity of the business and relationships with existing customers and allowing Alcon to begin its future growth plans to bring Hydrus Microstent to more international markets.
  • In 2020, Hoya Corporation formed joint venture with GeMax, a distributor partner. GeMax is a specialty promotion service provider of IOLs with a strong market position and a professional reputation in China, The joint venture is named as HOYA GeMax Medical (China).
  • In 2020, Bausch Health Companies Inc. announced the spin-off of its leading eye health business into an independent publicly traded entity ("Bausch + Lomb - NewCo") from the remainder of Bausch Health ("BHC"). It will consist of Bausch Health's global vision care, surgical, consumer and ophthalmic Rx businesses.

Top Key Players: -

The prominent players in the ophthalmic equipment market are Bausch Health Companies, Inc. (Canada), Alcon (Switzerland), Carl Zeiss Meditec AG (Germany), Johnson and Johnson (US), Hoya Corporation (Japan), The Cooper Companies, Inc.(US), EssilorLuxottica (France), Canon (Japan), Glaukos Corporation (US), Nidek Co., Ltd. (Japan), Topcon Corporation (Japan), Zeimer Ophthalmic Systems (Switzerland), Staar Surgical (US), Neo Vision (Korea), Clear Lab (Singapore), Appasamy Associates (India), Ophtec BV (Netherlands), Lumenis (Israel), and Intuvision Labs (India).

The Ophthalmic Equipment Industry is more than just a market; it's a beacon of hope for those seeking clarity in their vision. As someone deeply entrenched in the medical industry, I'm excited to witness this sector's growth as it advances towards a future where eye health knows no bounds. With continued advancements and global initiatives, the Ophthalmic Equipment Industry is set to make a profound impact on eye care worldwide.

 

Friday, August 25, 2023

Advancing Eye Care: The Evolving Landscape of Ophthalmic Equipment Market

 Increasing government initiatives to control visual impairment, technological advancements in ophthalmic devices, and the increasing adoption of contact lenses and spectacles are some of the key factors driving the market for ophthalmic equipment.

The report Ophthalmic Equipment Market  is projected to reach USD 80.9 billion by 2027 from USD 63.4 billion in 2022, at a CAGR of 5.0%.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155637364

KEY MARKET DYNAMICS

          1 DRIVERS

                   1 Increasing geriatric population        

                   2 Rising prevalence of eye disorders         

                   3 Technological advancements in ophthalmic devices     

                   4 Increased government initiatives to control visual impairment.

                   5 Rising adoption of contact lenses and spectacles

          2 RESTRAINTS

                    1 High cost and risk associated with eye surgeries.

                    2 Increased cost of ophthalmology devices

                    3 Rising adoption of refurbished ophthalmic devices

          3 OPPORTUNITIES

                    1 Potential growth opportunities in emerging markets

                    2 Low adoption of phacoemulsification devices and premium IOLs in emerging regions

          4 CHALLENGES

                    1 Low accessibility to eye care in low-income countries

                    2 Lack of skilled professionals

Market Segmentation:

·         Based on products, the ophthalmic equipment market is segmented into vision care products, surgical devices, and diagnostic and monitoring devices. The large share of the vision care products segment is attributed to the growing number of patients with refractive errors, increasing number of wearers, increasing prevalence of myopia, growing geriatric population, and increasing preference for contact lenses over prescription eyeglasses.

·         Based on end users, the market is segmented into consumers, hospitals, specialty clinics and ambulatory surgery centres, and other end users. The large share of consumers can be attributed to increasing emphasis on aesthetics, increasing usage of digital gadgets, growing adoption of spectacles and contact lenses among consumers.

Regional Analysis: -

In 2021, North America accounted for the largest share the ophthalmic equipment market. Market growth in this region is characterized by the high healthcare expenditure, rising geriatric population (and subsequent growth in the prevalence of eye diseases), and the availability of advanced ophthalmic devices in the country.

REQUEST FOR 10% CUSTOMIZATION:- https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=155637364

Recent Developments

  • In 2022, Alcon acquired Ivantis Inc. to help ensure continuity of the business and relationships with existing customers and allowing Alcon to begin its future growth plans to bring Hydrus Microstent to more international markets.
  • In 2020, Hoya Corporation formed joint venture with GeMax, a distributor partner. GeMax is a specialty promotion service provider of IOLs with a strong market position and a professional reputation in China, The joint venture is named as HOYA GeMax Medical (China).
  • In 2020, Bausch Health Companies Inc. announced the spin-off of its leading eye health business into an independent publicly traded entity ("Bausch + Lomb - NewCo") from the remainder of Bausch Health ("BHC"). It will consist of Bausch Health's global vision care, surgical, consumer and ophthalmic Rx businesses.

Top Key Players: -

The prominent players in the ophthalmic equipment market are Bausch Health Companies, Inc. (Canada), Alcon (Switzerland), Carl Zeiss Meditec AG (Germany), Johnson and Johnson (US), Hoya Corporation (Japan), The Cooper Companies, Inc.(US), EssilorLuxottica (France), Canon (Japan), Glaukos Corporation (US), Nidek Co., Ltd. (Japan), Topcon Corporation (Japan), Zeimer Ophthalmic Systems (Switzerland), Staar Surgical (US), Haag-Streit (Switzerland), Quantel Medical (US), Coburn Technologies, Inc. (US), FCI Ophthalmics (US), Matronix India Corporation (India), HEINE Optotechnik (Germany), Visionix (France), Neo Vision (Korea), Clear Lab (Singapore), Appasamy Associates (India), Ophtec BV (Netherlands), Lumenis (Israel), and Intuvision Labs (India).

 

Wednesday, June 28, 2023

Clearer Vision for the Future: Key Drivers Shaping the Ophthalmic Equipment Market

 Increasing government initiatives to control visual impairment, technological advancements in ophthalmic devices, and the increasing adoption of contact lenses and spectacles are some of the key factors driving the market for ophthalmic equipment.

The report Ophthalmic Equipment Market  is projected to reach USD 80.9 billion by 2027 from USD 63.4 billion in 2022, at a CAGR of 5.0%.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155637364

KEY MARKET DYNAMICS

          1 DRIVERS

                   1 Increasing geriatric population        

                   2 Rising prevalence of eye disorders         

                   3 Technological advancements in ophthalmic devices     

                   4 Increased government initiatives to control visual impairment.

                   5 Rising adoption of contact lenses and spectacles

          2 RESTRAINTS

                    1 High cost and risk associated with eye surgeries.

                    2 Increased cost of ophthalmology devices

                    3 Rising adoption of refurbished ophthalmic devices

          3 OPPORTUNITIES

                    1 Potential growth opportunities in emerging markets

                    2 Low adoption of phacoemulsification devices and premium IOLs in emerging regions

          4 CHALLENGES

                    1 Low accessibility to eye care in low-income countries

                    2 Lack of skilled professionals

Market Segmentation:

·         Based on products, the ophthalmic equipment market is segmented into vision care products, surgical devices, and diagnostic and monitoring devices. The large share of the vision care products segment is attributed to the growing number of patients with refractive errors, increasing number of wearers, increasing prevalence of myopia, growing geriatric population, and increasing preference for contact lenses over prescription eyeglasses.

·         Based on end users, the market is segmented into consumers, hospitals, specialty clinics and ambulatory surgery centres, and other end users. The large share of consumers can be attributed to increasing emphasis on aesthetics, increasing usage of digital gadgets, growing adoption of spectacles and contact lenses among consumers.

Regional Analysis: -

In 2021, North America accounted for the largest share the ophthalmic equipment market. Market growth in this region is characterized by the high healthcare expenditure, rising geriatric population (and subsequent growth in the prevalence of eye diseases), and the availability of advanced ophthalmic devices in the country.

REQUEST FOR 10% CUSTOMIZATION:- https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=155637364

Recent Developments

  • In 2022, Alcon acquired Ivantis Inc. to help ensure continuity of the business and relationships with existing customers and allowing Alcon to begin its future growth plans to bring Hydrus Microstent to more international markets.
  • In 2020, Hoya Corporation formed joint venture with GeMax, a distributor partner. GeMax is a specialty promotion service provider of IOLs with a strong market position and a professional reputation in China, The joint venture is named as HOYA GeMax Medical (China).
  • In 2020, Bausch Health Companies Inc. announced the spin-off of its leading eye health business into an independent publicly traded entity ("Bausch + Lomb - NewCo") from the remainder of Bausch Health ("BHC"). It will consist of Bausch Health's global vision care, surgical, consumer and ophthalmic Rx businesses.

Top Key Players: -

The prominent players in the ophthalmic equipment market are Bausch Health Companies, Inc. (Canada), Alcon (Switzerland), Carl Zeiss Meditec AG (Germany), Johnson and Johnson (US), Hoya Corporation (Japan), The Cooper Companies, Inc.(US), EssilorLuxottica (France), Canon (Japan), Glaukos Corporation (US), Nidek Co., Ltd. (Japan), Topcon Corporation (Japan), Zeimer Ophthalmic Systems (Switzerland), Staar Surgical (US), Haag-Streit (Switzerland), Quantel Medical (US), Coburn Technologies, Inc. (US), FCI Ophthalmics (US), Matronix India Corporation (India), HEINE Optotechnik (Germany), Visionix (France), Neo Vision (Korea), Clear Lab (Singapore), Appasamy Associates (India), Ophtec BV (Netherlands), Lumenis (Israel), and Intuvision Labs (India).

 

Antibody Therapeutics Market : Driven by Advances in Biologics and Expanding Clinical Applications

The global antibody therapeutics market is projected to grow from USD 311.2 billion in 2026 to USD 597.1 billion by 2035, at a CAGR of 7.5...